Phioanh L. Nghiemphu

Research interests

Publications

• NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022

  Journal of the National Comprehensive Cancer Network · 2023 · 10.6004/jnccn.2023.0002

• Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

  Nature Medicine · 2019 · 10.1038/s41591-018-0337-7

• Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC

  Neuro-Oncology · 2018 · https://doi.org/10.1093/neuonc/noy075

• Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

  Science Translational Medicine · 2016 · https://doi.org/10.1126/scitranslmed.aad9784

• Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

  Cancer Discovery · 2012 · https://doi.org/10.1158/2159-8290.cd-11-0284

• Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

  American Journal of Neuroradiology · 2012 · 10.3174/ajnr.a2950

• Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

  American Journal of Neuroradiology · 2012 · 10.3174/ajnr.a3253

• Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.33.8715

• Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

  Journal of Clinical Oncology · 2010 · 10.1200/jco.2010.30.2729

• Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment

  Radiology · 2009 · 10.1148/radiol.2521081534

• Bevacizumab and chemotherapy for recurrent glioblastoma

  Neurology · 2009 · 10.1212/01.wnl.0000345668.03039.90

• Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

  Nature Biotechnology · 2008 · https://doi.org/10.1038/nbt.1513

• Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

  PLoS Medicine · 2008 · 10.1371/journal.pmed.0050008

• MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy

  Neurology · 2006 · 10.1212/01.wnl.0000208958.29600.87

• Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain

  PLoS Medicine · 2006 · 10.1371/journal.pmed.0030485

Current projects

No projects listed.